Real-world data suggest that high-dose formulation ferric carboxymaltose injection (Injectafer; Daiichi Sankyo, Inc) may be a more cost-effective option for patients requiring IV iron therapy ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback